O'Loughlin Steve — SEC Form 4 filings

SEC reporting owner CIK 1615840. 2 Form 4 filings on record with FilingPulse; latest filed 2026-03-04.

Transaction summary — filings shown

Covers all 2 filings on record, filed 2025-04-02 to 2026-03-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Actinium Pharmaceuticals, Inc. (ATNM)Chief Financial Officer19
CNS Pharmaceuticals, Inc. (CNSP)Chief Financial Officer11

Form 4 filings — O'Loughlin Steve

FiledFormIssuerReported transactionsSource
2026-03-044CNS Pharmaceuticals, Inc. (CNSP)Grant/award (A): 9,500 (derivative)EDGAR
2025-04-024Actinium Pharmaceuticals, Inc. (ATNM)Disposition to issuer (D): 3,333 (derivative) @ $0 · Disposition to issuer (D): 1,666 (derivative) @ $0 · Disposition to issuer (D): 3,333 (derivative) @ $0 · Disposition to issuer (D): 8,833 (derivative) @ $0 · Disposition to issuer (D): 13,333 (derivative) @ $0 · Disposition to issuer (D): 59,066 (derivative) @ $0 · +3 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1615840 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →